Navigation Links
Survival Data for Avicena's Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND
Date:10/18/2007

our ability to control or predict. See "Risk Factors" under "Item 6. Management's Discussion and Analysis of Financial Condition and Results of Operation" from our Annual Report on Form 10-KSB for the year ended December 31, 2006, and other descriptions in the Company's public filings with the Securities and Exchange Commission for a discussion of such risks, including the Company's need for additional funds, the Company's dependence on a limited number of therapeutic compounds, the stage of the products the Company is developing, uncertainties relating to clinical trials and regulatory reviews, competition and dependence on collaborative partners, the Company's ability to avoid infringement of the patent rights of others, and the Company's ability to obtain adequate patent protection and to enforce these rights. Because of these risks, uncertainties and assumptions, you should not place undue reliance on these forward-looking statements. Furthermore, forward-looking statements speak only as of the date they are made. Avicena does not undertake any obligation to update or review any such forward-looking information, whether as a result of new information, future events or otherwise.

Contact:

The Ruth Group (on behalf of Avicena Group)

Sara Ephraim (investors)

(646) 536-7002

sephraim@theruthgroup.com

Janine McCargo / Jason Rando (media)

(646) 536-7033 / 7025

jmccargo@theruthgroup.com or jrando@theruthgroup.com


'/>"/>
SOURCE Avicena Group, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
2. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
3. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
4. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
5. Velcade (bortezomib) for Injection Survival Data in Front-Line Multiple Myeloma Patients to be Featured at 11th International Myeloma Workshop
6. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
7. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
8. Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal Women with Early Breast Cancer Receiving Treatment with Tamoxifen
9. Ivivis PEMF Technology Significantly Improves Neuron Survival in Parkinsons Disease Model, Study Finds
10. Synta Presents Results for STA-4783 in Metastatic Melanoma Showing Improvement in Overall Survival
11. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... , July 10, 2014   Ventana Medical ... today announced it has entered into an agreement with ... operates as EMD Serono in the United ... to collaborate with Merck KGaA,s biopharmaceutical division on the ... an undisclosed target using Ventana,s proprietary diagnostic assays. In ...
(Date:1/15/2014)... Jan. 15, 2014 Sono-Tek Corporation (OTC BB: SOTK) today ... 30, 2013, compared to sales of $2,202,000 for the prior ... this quarter has also shown growth over the preceding quarter,s ... of this fiscal year. Markets that experienced sales increases over ...
(Date:1/15/2014)... today announced it has established a relief fund ... that has gripped much of the nation. AARP and its ... support these emergency relief efforts AARP and AARP Foundation will ... to $500,000 in aid. The matching program will be administered ...
Breaking Medicine Technology:Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3Sono-Tek Announces Third Quarter Results 2Sono-Tek Announces Third Quarter Results 3Sono-Tek Announces Third Quarter Results 4AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3
(Date:7/11/2014)... 11, 2014 Los Angeles dental ... he uses mini and full mouth implants to replace ... feature that distinguishes dental implants from other tooth replacements: ... the crowns. This alone prevents the long-term complications of ... advantages related to comfort, appearance and systemic health. Mini ...
(Date:7/11/2014)... Maureen Salamon HealthDay Reporter ... the millions of women who can,t cough, sneeze or ... treatment that uses stem cells to regenerate weakened urethra ... found that injecting stem cells isolated from patients, own ... participants within a year. Stress incontinence affects ...
(Date:7/11/2014)... 11, 2014 Recent research findings regarding Fourth ... atmosphere, and how water affects human bodies. That was the ... during an interview on the Sharon Kleyne Hour Power of ... , Gerald Pollack, PhD, is a Professor of Bioengineering at ... Phase of Water (Ebner & Sons, 2013). , ...
(Date:7/11/2014)... WA (PRWEB) July 11, 2014 Shoulder ... the rate of return to play has not been ... the American Orthopaedic Society for Sports Medicine’s ( AOSSM ... NFL players is approximately 90 percent no matter what ... highlighted the success rate of return to play following ...
(Date:7/11/2014)... (ACL) reconstructions occur more than 200,000 times a year, ... new ligament may determine how long you stay in ... the Annual Meeting of the American Orthopaedic Society of ... highlight that in a young athletic population, allografts (tissue ... autografts (tissue harvested from the patient)," said Craig R. ...
Breaking Medicine News(10 mins):Health News:Dental Implant Dentist, Kevin Sands DDS, Now Uses Mini and Full Mouth Implants to Replace Missing Teeth 2Health News:Stem Cells May Ease Urinary Incontinence, Study Says 2Health News:Stem Cells May Ease Urinary Incontinence, Study Says 3Health News:Recent Fourth Phase Water Discoveries Alter Basic Understanding of Life, Claims Researcher on Sharon Kleyne Hour 2Health News:Recent Fourth Phase Water Discoveries Alter Basic Understanding of Life, Claims Researcher on Sharon Kleyne Hour 3Health News:Stabilizing Shoulder Surgery Helps NFL Players Return to the Game 2Health News:ACL reconstructions may last longer with autografts 2
... forced migrations, refugee crisis, large-scale rape of women in sub-Saharan ... that area is a myth. This is according to a ... published this week in the British medical journal The Lancet. ... conflict spread HIV infection in host communities; the reverse may ...
... that regular vaccination of infants against H. influenzae type ... and meningitis, could save innumerable children in Asia. ... online in The Pediatric Infectious Disease Journal, has established ... vaccine prevented more than one-third of acute pneumonia cases ...
... found that a new type of engineered drug may have ... ,The study by researchers at the Ohio State University Comprehensive ... ,The research has established that an engineered drug ... tube and early animal tests. ,The agent ...
... Abuse and Alcoholism (NIAAA), a part of the U.S. ... subtypes of alcoholism by analysing a national sample ... findings should help dispel the popular notion of the ... NIAAA Associate Director for Clinical and Translational Research. ...
... Anxiety disorders seem to afflict humans very early, not sparing even ... for anxiety disorders in New South Wales in Australia. ... figures released by Macquarie University's Anxiety Research Unit show. ... per cent compared to a rate of about 1 per ...
... revealed that the secret of his relatively wrinkle-free visage at the ... ,The slender rock star, notorious for his wild ... applies a special cream under his eyes in order to keep ... the Daily Express quotes him as saying. ,"I ...
Cached Medicine News:Health News:War Spreading AIDS a Myth-UNHCR 2Health News:Routine Hib Vaccination Could Save Innumerable Asian Children 2Health News:Routine Hib Vaccination Could Save Innumerable Asian Children 3Health News:New Engineered Drug Shows Promise in Treating Lymphocytic Leukaemia 2Health News:Researchers Identify Five Distinct Subtypes of Alcoholism 2Health News:Researchers Identify Five Distinct Subtypes of Alcoholism 3Health News:Anxiety Disorders Show in Tiny Tots 2
Full automatic, ready-to-use strip washer....
MultiWash Advantage is a versatile microplate washer engineered for reliability. It is designed for lab environments to help streamline their daily processes....
Synchron Hemoglobin A1c (HbA1c) utilizes two unique cartridges, Hb and A1c, to determine HbA1c concentration as a percentage of total hemoglobin....
... HbA1c Testing , Monoclonal antibody ... precision , Correlation study shows 99% agreement ... you can count on a CV ... , National Glycohemoglobin Standardization Program (NGSP) certified ...
Medicine Products: